Grifols, S.A Revenue 2012-2019 | GRFS

Grifols, S.A annual/quarterly revenue history and growth rate from 2012 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Grifols, S.A revenue for the quarter ending June 30, 2019 was $1.424B, a 20.01% increase year-over-year.
  • Grifols, S.A revenue for the twelve months ending June 30, 2019 was $5.107B, a 13.96% increase year-over-year.
  • Grifols, S.A annual revenue for 2018 was $5.299B, a 8.57% increase from 2017.
  • Grifols, S.A annual revenue for 2017 was $4.881B, a 8.91% increase from 2016.
  • Grifols, S.A annual revenue for 2016 was $4.482B, a 2.58% increase from 2015.
Grifols, S.A Annual Revenue
(Millions of US $)
2018 $5,299
2017 $4,881
2016 $4,482
2015 $4,369
2014 $4,460
2013 $3,642
2012 $3,371
2011 $2,501
Grifols, S.A Quarterly Revenue
(Millions of US $)
Q2 2019 $1,424
Q2 2018 $1,308
Q2 2017 $1,244
Q1 2017 $1,131
Q4 2016 $1,186
Q3 2016 $1,116
Q2 2016 $1,121
Q1 2016 $1,058
Q4 2015 $1,166
Q3 2015 $1,081
Q2 2015 $1,097
Q1 2015 $1,023
Q4 2014 $1,041
Q3 2014 $1,098
Q2 2014 $1,086
Q1 2014 $1,111
Q4 2013 $923
Q3 2013 $882
Q2 2013 $925
Q1 2013 $903
Q4 2012 $851
Q3 2012 $804
Q2 2012 $835
Q1 2012 $863
Q4 2011 $796
Q3 2011 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.941B $5.299B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.471B 39.61
Takeda Pharmaceutical (TAK) Japan $60.597B 10.74
Astellas Pharma (ALPMY) Japan $32.582B 16.27
Eisai (ESALY) Japan $23.185B 44.70
Merck (MKGAF) Germany $17.215B 23.49
Neurocrine Biosciences (NBIX) United States $9.626B 267.44
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.851B 36.42
Ionis Pharmaceuticals (IONS) United States $8.458B 17.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.968B 10.18
IPSEN SA ADR (IPSEY) France $6.104B 0.00
Orion OYJ (ORINY) Finland $5.871B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.461B 16.61
United Therapeutics (UTHR) United States $4.572B 0.00
Evotec AG (EVTCY) Germany $4.261B 68.88
Arrowhead Pharmaceuticals (ARWR) United States $4.195B 77.87
Nektar Therapeutics (NKTR) United States $4.069B 0.00
FibroGen (FGEN) United States $3.977B 116.87
PTC Therapeutics (PTCT) United States $3.559B 0.00
Sage Therapeutics (SAGE) United States $3.528B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.790B 11.29
ChemoCentryx (CCXI) United States $2.786B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.092B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.086B 61.72
Xencor (XNCR) United States $2.070B 62.91
Ironwood Pharmaceuticals (IRWD) United States $1.891B 23.19
Heron Therapeutics (HRTX) United States $1.891B 0.00
Tilray (TLRY) Canada $1.748B 0.00
USANA Health Sciences (USNA) United States $1.626B 17.00
Corcept Therapeutics (CORT) United States $1.525B 18.53
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.469B 10.02
Zogenix (ZGNX) United States $1.424B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.424B 0.00
Endo (ENDP) Ireland $1.395B 2.56
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Akebia Therapeutics (AKBA) United States $1.041B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 32.03
Dermira (DERM) United States $1.022B 0.00
ImmunoGen (IMGN) United States $1.018B 0.00
Karyopharm Therapeutics (KPTI) United States $0.966B 0.00
Radius Health (RDUS) United States $0.922B 0.00
Aerie Pharmaceuticals (AERI) United States $0.901B 0.00
Collegium Pharmaceutical (COLL) United States $0.775B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.631B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.536B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.492B 59.63
BioSpecifics Technologies Corp (BSTC) United States $0.478B 20.59
Ardelyx (ARDX) United States $0.474B 0.00
Translate Bio (TBIO) United States $0.471B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.444B 0.00
Innate Pharma SA (IPHYF) France $0.442B 0.00
Organogenesis Holdings (ORGO) United States $0.431B 0.00
Recro Pharma (REPH) United States $0.420B 0.00
Indivior (INVVY) United States $0.417B 2.48
BioCryst Pharmaceuticals (BCRX) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.393B 8.98
DURECT (DRRX) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Lannett Co Inc (LCI) United States $0.367B 5.91
Calithera Biosciences (CALA) United States $0.366B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.356B 0.00
Rafael Holdings (RFL) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.320B 0.00
OptiNose (OPTN) United States $0.285B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.272B 0.00
KalVista Pharmaceuticals (KALV) United States $0.270B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.267B 0.00
Ocular Therapeutix (OCUL) United States $0.250B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.228B 0.00
MEI Pharma (MEIP) United States $0.227B 0.00
IMV INC (IMV) Canada $0.213B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Nature's Sunshine Products (NATR) United States $0.205B 35.27
Taiwan Liposome (TLC) Taiwan $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.194B 2.60
AcelRx Pharmaceuticals (ACRX) United States $0.127B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.124B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
Otonomy (OTIC) United States $0.114B 0.00
Aquestive Therapeutics (AQST) United States $0.110B 0.00
Redhill Biopharma (RDHL) Israel $0.110B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.108B 0.00
Xeris Pharmaceuticals (XERS) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.097B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.23
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.052B 23.44
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
PolarityTE (PTE) United States $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00